AMERIGEN PHARMACEUTICALS
Live / Registered — Registered (as of 08 Oct 2019)
What this means for you
Registered since 08 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86858716
- Registration number
- 5880320
- Mark type
- Stylized text
- Filed
- 28 Dec 2015
- Published for opposition
- 24 May 2016
- Registered
- 08 Oct 2019
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of hypertension, cardiovascular disease, neurological disorders, attention-deficit hyperactivity disorder, Parkinson's disease, oncology, metabolic disorders, Gaucher's disease and Wilson's disease
Owner
- Amerigen Pharmaceuticals, Ltd., KY1-1111, KY
- Amerigen Pharmaceuticals, Ltd., KY1-1111, KY
- Amerigen Pharmaceuticals, Ltd., KY1-1111, KY
Prosecution history
- 08 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 Sept 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Sept 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Sept 2020 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 03 Sept 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Sept 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Sept 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 22 Jan 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 08 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 06 Sept 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Sept 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Aug 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Jul 2019 — USE AMENDMENT FILED
- 12 Jul 2019 — TEAS STATEMENT OF USE RECEIVED
- 21 Dec 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED